Traditional NBS uptake has been slow, now new technology is launching pilot projects in NBS by genome sequencing for hundreds of treatable diseases. In this Rarity podcast episode, Dr. Stephen Kingsmore joins to discuss the future of NBS including opportunities and barriers to implementation.
